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Abstract
Aims/hypothesis The association between depression and
insulin resistance has been investigated in only a few
studies, with contradictory results reported. The aim of this
study was to determine whether the association between
symptoms of depression and insulin resistance varies across
glucose tolerance status and between men and women.
Subjects and methods Cross-sectional data from a popula-
tion-based cohort study in Hoorn, a medium-sized town in
the Netherlands, were analysed. The study sample consisted
of 541 men and women aged 55–75 years, of whom 260
had NGT, 164 had IGT and 117 had established type 2
diabetes mellitus. Main outcome measures were insulin
resistance defined by the homeostasis model assessment for
insulin resistance (HOMA-IR) and symptoms of depression
using the Centre for Epidemiologic Studies Depression
Scale (CES-D).
Results In the total sample, we found a weak positive
correlation between the depressive symptoms CED-D
scores and HOMA-IR scores (rs=0.156, p<0.001). Even
weaker associations were found in subjects with NGT
(rs=0.041, p=0.509), in subjects with IGT (rs=0.112,
p=0.160) and in subjects with type 2 diabetes (rs=0.007,
p=0.942). The association between depressive symptoms
and insulin resistance was similar for men and women.
Conclusions/interpretation We found only weak associa-
tions between depressive symptoms and insulin resistance,
which did not differ among different glucose metabolism
subgroups or between men and women.
Keywords Depressive symptoms . Hoorn Study .
Insulin resistance . Population-based cohort
Abbreviations




homeostasis model assessment for insulin
resistance
QUICKI quantitative insulin sensitivity check index
Introduction
A recent meta-analysis of nine prospective epidemiological
studies showed that depression is associated with an
increased risk of incident type 2 diabetes [1]. The
relationship between depression and insulin resistance is,
however, less clear. So far three studies have reported on
the association between depression and insulin resistance.
A cross-sectional study by Lawlor and colleagues reported
that depression was inversely related to insulin resistance
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among 4,268 British woman aged 60–79 years [2]. In
contrast, a study by Timonen et al. in 491 male and female
elderly Finnish individuals aged 61–63 years showed that
insulin resistance and severity of depressive symptoms
were positively correlated, particularly in people with IGT
[3]. However, in a prospective cohort study, Lawlor and her
colleagues concluded that reduced depressive symptoms
were not associated with insulin resistance among 2,512
Welsh men aged 45–59 years [4].
These apparently contradictory results may be due to
differences in methodology (longitudinal vs cross-sectional)
and patient samples (men vs women). Of particular interest
is whether the association between symptoms of depression
with insulin resistance is different between men and women
and across glucose tolerance status [5]. Therefore, we asked
the following research questions: (1) Is a higher level of
depression symptoms associated with increased insulin
resistance in the total sample; and (2) does this association
differ across glucose tolerance status and between sexes?
We tested these hypotheses using cross-sectional data of a
population-based cohort from The Hoorn Study.
Subjects and methods
Subjects The Hoorn Study is a population-based cohort
study of type 2 diabetes in the general Dutch population.
Details of the study have been described before [6]. In
summary, it consisted of 2,844 men and women aged 50–
75 years at baseline, selected from the population register of
the medium-sized Dutch town of Hoorn. In 2000–2001, a
third examination was performed among surviving partici-
pants who gave their permission to be re-contacted. We
invited all participants who had diabetes, as determined by
a 75-g OGTT or by diabetes treatment (n=176) at the
second examination of the entire cohort in 1996–1998 [7].
We also invited random samples of participants who had
NGT (n=705) or IGT (n=193) in 1996–1998. Of 1,074
individuals invited, 648 (60.3%) participated. The main
reasons for not participating in the 2000–2001 follow-up
examination are described elsewhere [8]. We assessed the
cross-sectional relationship between depressive symptoms
and insulin resistance in a cohort of 541 men and woman
aged 55–75 years, of whom 260 had NGT, 164 IGT and
117 established type 2 diabetes mellitus. All subjects gave
written informed consent and the Ethical Review Commit-
tee of the VU University Medical Centre approved the
Study.
Methods All subjects underwent a single 75-g OGTT.
Fasting glucose and 2-h post-load glucose after OGTT
were measured in plasma with the hexokinase method
(Roche Diagnostics, Mannheim, Germany). Glucose toler-
ance status was defined according to WHO 1999. Subjects
were classified as having NGT, IGT (i.e. impaired fasting
glucose or IGT), or type 2 diabetes mellitus.
Insulin resistance was estimated by the homeostasis
model assessment for insulin resistance (HOMA-IR),
calculated as (fasting insulin [in μU/ml] × fasting glucose
[in mmol/l])/22.5, in line with Lawlor et al. [2, 4]. We also
used the quantitative insulin sensitivity check index
(QUICKI=1/[log (fasting insulin)+log (fasting glucose)]).
Symptoms of depression during the previous week were
measured using the validated Dutch version of the 20-item
Centre for Epidemiologic Studies Depression Scale (CES-
D), with higher scores indicating more severe symptom-
atology. The Dutch translation of this instrument has been
shown to have good psychometric properties and satisfac-
tory criterion validity [9]. The CES-D total score can range
from 0 to 60.
Analysis Descriptive statistics (means and 95% CIs) and
correlations of the primary outcome measures CES-D and
HOMA-IR in different glucose tolerance categories are
presented. One-way ANOVAs were used to test whether
CES-D and HOMA-IR scores differed between the three
glucose status groups. Because of the skewed distribution of
HOMA-IR scores, we used the non-parametric Spearman’s
rho to assess the association between depressive symptoms
and insulin resistance. All analyses were performed sepa-
rately for men and women. For all statistical testing, we used
two-sided hypothesis testing with an alpha level of 0.05.
Statistical analyses were performed using the SPSS 11.5
software package for Windows.
Results
Mean CES-D (p=0.002) and HOMA-IR (p<0.001) scores
were significantly different between the three glucose status
groups (Table 1). In the total sample, we found a weak posi-
tive correlation between the depressive symptoms CES-D
scores and insulin resistance HOMA-IR scores (rs=0.156,
p<0.001; data not shown). Even weaker associations were
found in subjects with NGT (rs=0.041, p=0.509), in
subjects with IGT (rs=0.112, p=0.160) and in subjects
with type 2 diabetes (rs=0.007, p=0.942). The association
between depressive symptoms and insulin resistance was
not different for men and women. Finally, to make the
analysis more robust we conducted a two-way ANOVA
with sex and glucose tolerance status as independent
variables and depression as the dependent variable. We
found no significant interaction effect of sex × glucose
tolerance status on depression (F=0.99; p=0.371).
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Discussion
In the total sample, symptoms of depression and insulin
resistance appeared to be only weakly associated. In
addition, we found no evidence that this association is
different for men and women or for people with different
stages of disturbed glucose metabolism. The strengths of
our study are that we used data from a large population-
based sample of male and female subjects with documented
glucose intolerance. Timonen et al. [3] used QUICKI,
instead of the HOMA-IR scores used by Lawlor et al. [2, 4]
and by us. However, in our study QUICKI and HOMA-IR
had a perfect non-parametric correlation (rs=−1.00). Like-
wise the rho correlations between QUICKI and depressive
symptoms varied from −0.101 to 0.019. Therefore, we
believe it is unlikely that the use of different definitions of
insulin sensitivity or insulin resistance has seriously biased
the results in the studies that have been conducted so far.
This study also had some limitations. For example, we
used a self-report measure (CES-D) to assess symptoms of
depression during the previous week, while the psychiatric
diagnostic interview is the gold standard. However, the
sensitivity of the CES-D to detect major depressive disorder
is high [9]. In addition, the majority of subjects in our study
had few symptoms indicative of depression. In our sample,
9% (24 of 271) of the men and 15% (41 of 270) of the
women had a CES-D score ≥16, which is a generally
accepted threshold for increased depression. As a result we
could not test whether chronic or more severe depression is
causally associated with insulin resistance. One could also
question the validity of the HOMA-IR regarding the exact
assessment of insulin resistance. The gold standard for
measuring insulin resistance is the hyperinsulinaemic–
euglycaemic glucose clamp technique, but this is not easy
to apply in epidemiological studies. Yet several studies
report that HOMA-IR scores correlate well with estimates
from the euglycaemic clamp. Discrepancies in previous
studies [2–4] may be explained by confounding by glucose
status, which had not been determined.
The role of depression in the aetiology of insulin
resistance and type 2 diabetes is not well understood.
Further well-designed research is needed to establish the
magnitude and direction of the relationship, particularly
with regard to chronic symptoms of depression and
development of insulin resistance and subsequent type 2
diabetes mellitus. Ideally, future population-based cohort
studies should have a prospective design and include
psychiatric diagnostic interviews, validated self-report
depression measures and accurate insulin resistance mea-
sures (euglycaemic clamp data).
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Correlation between HOMA-IR and CES-D
Men and women
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p value 0.509 0.160 0.942
Mend
n 129 84 54
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p value 0.712 0.517 0.891
Women
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a Fasting glucose <6.1 mmol/l and 2-h blood glucose <7.8 mmol/l in
OGTT
b Fasting glucose ≥6.1 mmol/l and <7.0 mmol/l or 2-h blood glucose
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